🔎 Trials Near Me

Gara Jalqabaatti › Burkitt Lymphoma

Qorannoo klinikaalii Burkitt Lymphoma Ameerikaa Keessatti hirmaatuu

Qorannoo 63 Burkitt Lymphoma f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 1 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07223021

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 39 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03150693

Blinatumomab Consolidation in Real World

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 0 hanga 38 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06131801

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 3 hanga 39 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05442515

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT03223610

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06144606

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Namoota walitti qabaa jiraSadarkaa 1/2
6 Months – 25 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06395103

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Namoota walitti qabaa jiraSadarkaa 1/2
31 Days – 30 Years · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT04544592

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Namoota walitti qabaa jiraSadarkaa 3
365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05389423

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT06137118

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 7 hanga 25 · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT05082519

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06340737

LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 81 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT05990465

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.